Invention Grant
- Patent Title: Compositions and methods for regulating NK cell activity
- Patent Title (中): 调节NK细胞活性的组成和方法
-
Application No.: US12813040Application Date: 2010-06-10
-
Publication No.: US08637258B2Publication Date: 2014-01-28
- Inventor: Soren Berg Padkjaer , Alessandro Moretta , Mariella Della Chiesa , Pascale Andre , Laurent Gauthier , Peter Andreas Nicolai Reumert Wagtmann
- Applicant: Soren Berg Padkjaer , Alessandro Moretta , Mariella Della Chiesa , Pascale Andre , Laurent Gauthier , Peter Andreas Nicolai Reumert Wagtmann
- Applicant Address: DK Bagsvaerd IT Genoa FR Marseille
- Assignee: Novo Nordisk A/S,University of Genoa,Innate Pharma, S.A.
- Current Assignee: Novo Nordisk A/S,University of Genoa,Innate Pharma, S.A.
- Current Assignee Address: DK Bagsvaerd IT Genoa FR Marseille
- Agency: LeClairRyan, a professional corporation
- Agent Robin Teskin
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/567 ; C12P21/08 ; C07K16/00
Abstract:
The present invention relates to a method of producing an antibody that cross-reacts with multiple KIR2DL polypeptides and neutralizes the inhibitory activity of such polypeptides.
Public/Granted literature
- US20100291110A1 Compositions and Methods for Regulating NK Cell Activity Public/Granted day:2010-11-18
Information query
IPC分类:
